These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
565 related items for PubMed ID: 27306945
21. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H. Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913 [Abstract] [Full Text] [Related]
22. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study. Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. Nutrients; 2020 Jul 05; 12(7):. PubMed ID: 32635661 [Abstract] [Full Text] [Related]
23. Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. Wegh CAM, Benninga MA, Tabbers MM. J Clin Gastroenterol; 2018 Jul 05; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S10-S26. PubMed ID: 29782469 [Abstract] [Full Text] [Related]
24. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P. Dig Liver Dis; 2015 Feb 05; 47(2):119-24. PubMed ID: 25488056 [Abstract] [Full Text] [Related]
25. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Scand J Gastroenterol; 2013 Oct 05; 48(10):1127-35. PubMed ID: 23957590 [Abstract] [Full Text] [Related]
29. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P. Gastroenterology; 2017 Aug 05; 153(2):448-459.e8. PubMed ID: 28483500 [Abstract] [Full Text] [Related]
30. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Oh JH, Jang YS, Kang D, Chang DK, Min YW. Nutrients; 2019 Nov 27; 11(12):. PubMed ID: 31783597 [Abstract] [Full Text] [Related]
31. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG. J Gastroenterol Hepatol; 2014 Jan 27; 29(1):52-9. PubMed ID: 23829297 [Abstract] [Full Text] [Related]
32. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, Serra J. World J Gastroenterol; 2014 Jul 14; 20(26):8709-16. PubMed ID: 25024629 [Abstract] [Full Text] [Related]
33. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Pratt C, Campbell MD. Probiotics Antimicrob Proteins; 2020 Sep 14; 12(3):834-839. PubMed ID: 31741311 [Abstract] [Full Text] [Related]
34. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. World J Gastroenterol; 2016 Dec 28; 22(48):10631-10642. PubMed ID: 28082816 [Abstract] [Full Text] [Related]
35. Probiotics and functional gastrointestinal disorders in children. Vandenplas Y, Benninga M. J Pediatr Gastroenterol Nutr; 2009 Apr 28; 48 Suppl 2():S107-9. PubMed ID: 19300120 [Abstract] [Full Text] [Related]
36. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. Bauserman M, Michail S. J Pediatr; 2005 Aug 28; 147(2):197-201. PubMed ID: 16126049 [Abstract] [Full Text] [Related]
37. Probiotics for Irritable Bowel Syndrome: Clinical Data in Children. Giannetti E, Staiano A. J Pediatr Gastroenterol Nutr; 2016 Jul 28; 63 Suppl 1():S25-6. PubMed ID: 27380595 [Abstract] [Full Text] [Related]
38. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T. Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183 [Abstract] [Full Text] [Related]
39. [Long-term probiotic administration for irritable bowel syndrome: a legal need]. Solovyeva OI, Nekrasova AS, Topalova IG, Ponomarenko VA, Tsurtsumiia DB, Ilyashevich IG. Ter Arkh; 2023 Oct 11; 95(8):679-685. PubMed ID: 38158905 [Abstract] [Full Text] [Related]
40. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Sisson G, Ayis S, Sherwood RA, Bjarnason I. Aliment Pharmacol Ther; 2014 Jul 11; 40(1):51-62. PubMed ID: 24815298 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]